ABSI vs BMY · rev $533.0K vs P/E 17, rev $24.46B
Absci Corp (ABSI) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Absci Corp (ABSI) is a biotechnology company listed on NASDAQ.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported ABSI revenue for 2026-06-30 was $533.0K. Net income was -$62.8M. ABSI currently screens at market cap $1.13B.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
ABSI currently screens at market cap $1.13B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the ABSI and BMY stock pages for the full models.
Not investment advice.